These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
480 related items for PubMed ID: 8332901
1. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG. Science; 1993 Jul 16; 261(5119):358-61. PubMed ID: 8332901 [Abstract] [Full Text] [Related]
3. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. de Weers M, Mensink RG, Kraakman ME, Schuurman RK, Hendriks RW. Hum Mol Genet; 1994 Jan 16; 3(1):161-6. PubMed ID: 8162018 [Abstract] [Full Text] [Related]
5. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. Fukuda M, Kojima T, Kabayama H, Mikoshiba K. J Biol Chem; 1996 Nov 29; 271(48):30303-6. PubMed ID: 8939985 [Abstract] [Full Text] [Related]
10. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. Buhl AM, Cambier JC. J Immunol; 1999 Apr 15; 162(8):4438-46. PubMed ID: 10201980 [Abstract] [Full Text] [Related]
11. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. Webb CF, Yamashita Y, Ayers N, Evetts S, Paulin Y, Conley ME, Smith EA. J Immunol; 2000 Dec 15; 165(12):6956-65. PubMed ID: 11120822 [Abstract] [Full Text] [Related]
12. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase. Dingjan GM, Maas A, Nawijn MC, Smit L, Voerman JS, Grosveld F, Hendriks RW. EMBO J; 1998 Sep 15; 17(18):5309-20. PubMed ID: 9736610 [Abstract] [Full Text] [Related]
13. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis. Anderson JS, Teutsch M, Dong Z, Wortis HH. Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):10966-71. PubMed ID: 8855292 [Abstract] [Full Text] [Related]
14. xid affects events leading to B cell cycle entry. Brorson K, Brunswick M, Ezhevsky S, Wei DG, Berg R, Scott D, Stein KE. J Immunol; 1997 Jul 01; 159(1):135-43. PubMed ID: 9200448 [Abstract] [Full Text] [Related]
17. A new molecular genetic diagnosis of the Btk(xid) mice. Takagi Y, Masui N, Yasuda M, Ono S. Exp Anim; 2007 Jan 01; 56(1):63-6. PubMed ID: 17283893 [Abstract] [Full Text] [Related]
18. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan SP, Nilsson L, Smith CI, Witte ON, Chen SH, Ochs HD. J Exp Med; 1994 Aug 01; 180(2):461-70. PubMed ID: 7519238 [Abstract] [Full Text] [Related]
20. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse. Klaus GG, Holman M, Johnson-Léger C, Elgueta-Karstegl C, Atkins C. Eur J Immunol; 1997 Nov 01; 27(11):2749-56. PubMed ID: 9394795 [Abstract] [Full Text] [Related] Page: [Next] [New Search]